SKI Market

A+| A| A-|

Indian Indices

Sensex

75,381.62 -633.66
( -0.83%)

Global Indices

Nasdaq

49,723.13 92.96
(0.19%)

Dow Jones

7,432.82 12.89
(0.17%)

Hang Seng

62,457.26 -256.39
(-0.41%)

Nikkei 225

10,269.73 36.66
(0.36%)

Forex

USD-INR

94.41 0.04
(0.04%)

EUR-INR

111.23 0.30
(0.27%)

GBP-INR

128.63 0.31
(0.24%)

JPY-INR

0.60 0.00
(-0.10%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sunrest Lifescience Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

91669

INE0PLZ01012

36.3585943

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNREST

17.3

34.59

EPS(TTM)

Face Value()

Div & Yield %

2.33

Back

Relonchem receives UK MHRA's marketing approval for two products

Nov 17,2025

Marksans Pharma announced that its wholly owned subsidiary Relonchem in UK has received Marketing Authorization for its following products from UK MHRA:

1. Mefenamic Acid 250 mg Film-Coated Tablets
2. Mefenamic Acid 500 mg Film-Coated Tablets

75,381.62 -633.66 ( -0.83%)

49,723.13 92.96 (0.19%)

7,432.82 12.89 (0.17%)

62,457.26 -256.39 (-0.41%)

10,269.73 36.66 (0.36%)

94.41 0.04 (0.04%)

111.23 0.30 (0.27%)

128.63 0.31 (0.24%)

0.60 0.00 (-0.10%)